title: [Planned 3-dimensional low-volume conformal irradiation of a local prostatic carcinoma].
abstract: OBJECTIVE
  Recent data have shown a significant reduction of acute side effects by means of a three-dimensional planned conformal radiotherapy of carcinoma of the prostate compared to treatment techniques used before. Theoretically, an optimized field coverage of the planning target volume should result in a reduction of treated bladder and rectum volumes. We studied the effects of individualized blocks on treatment volumes, planning target volumes, irradiated bladder and rectum volumes on basis of three-dimensional treatment planning by means of beam's-eye-view technique.
  
  
  METHODS
  We compared dose-volume-histograms of 2 different planning models, a (fictitious) open 4-field-box-technique and a technique with conformal blocked fields designed from the beam's-eye-view display (prescribed dose 66 Gy, daily single fraction 2 Gy). Plans of 115 patients with localized prostate cancer treated from January 1994 to February 1996 were analyzed.
  
  
  RESULTS
  Using individualized fields treatment volume (covered by the 90%-isodose) was reduced by 23% on the average in comparison to the planning model without blocks. The averaged difference of treated volume and planning target volume, as a grade of efficiency of conformation, was reduced by 38% (496 cm3 303 cm3) using individualized blocks. 23% of the treated bladder volume and 13% of the treated rectum volume had been saved on the average. Nevertheless, at least 11.5% of the bladder volume and 27.6% of the contoured rectum volume were treated with the prescribed dose (55 Gy = 100%).
  
  
  CONCLUSIONS
  The comparison of dose-volume-histogram-data showed that especially high dose volumes of organs at risk had been saved by means of individualized blocks created from the beam's-eye-view. The blocks did not affect the dose distribution of the planning target volume adversely. Consequently the impact of these data on the extent of side effects and local tumor control has to be proven.
authors.affiliation: Universitätsklinik für Strahlentherapie und Strahlenbiologie, Wien.
authors.forename: S
authors.initials: S
authors.lastname: Wachter
authors.forename: N
authors.initials: N
authors.lastname: Gerstner
authors.forename: K
authors.initials: K
authors.lastname: Dieckmann
authors.forename: M
authors.initials: M
authors.lastname: Stampfer
authors.forename: R
authors.initials: R
authors.lastname: Hawliczek
authors.forename: R
authors.initials: R
authors.lastname: Pötter
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011467:Prostate / Q000000981:diagnostic imaging; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000295:instrumentation / Q000379:methods* / Q000706:statistics & numerical data; D014057:Tomography, X-Ray Computed